Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;39(1):19-26.
doi: 10.1007/s00774-020-01162-6. Epub 2020 Oct 20.

Osteoclast differentiation by RANKL and OPG signaling pathways

Nobuyuki Udagawa  1   2 , Masanori Koide  3 , Midori Nakamura  4   3 , Yuko Nakamichi  3 , Teruhito Yamashita  3 , Shunsuke Uehara  4 , Yasuhiro Kobayashi  3 , Yuriko Furuya  5 , Hisataka Yasuda  5 , Chie Fukuda  6 , Eisuke Tsuda  6
Affiliations
Review

Osteoclast differentiation by RANKL and OPG signaling pathways

Nobuyuki Udagawa et al. J Bone Miner Metab. 2021 Jan.

Abstract

Introduction: In bone tissue, bone resorption by osteoclasts and bone formation by osteoblasts are repeated continuously. Osteoclasts are multinucleated cells that derive from monocyte-/macrophage-lineage cells and resorb bone. In contrast, osteoblasts mediate osteoclastogenesis by expressing receptor activator of nuclear factor-kappa B ligand (RANKL), which is expressed as a membrane-associated cytokine. Osteoprotegerin (OPG) is a soluble RANKL decoy receptor that is predominantly produced by osteoblasts and which prevents osteoclast formation and osteoclastic bone resorption by inhibiting the RANKL-RANKL receptor interaction.

Materials and methods: In this review, we would like to summarize our experimental results on signal transduction that regulates the expression of RANKL and OPG.

Results: Using OPG gene-deficient mice, we have demonstrated that OPG and sclerostin produced by osteocytes play an important role in the maintenance of cortical and alveolar bone. In addition, it was shown that osteoclast-derived leukemia inhibitory factor (LIF) reduces the expression of sclerostin in osteocytes and promotes bone formation. WP9QY (W9) is a peptide that was designed to be structurally similar to one of the cysteine-rich TNF-receptortype-I domains. Addition of the W9 peptide to bone marrow culture simultaneously inhibited osteoclast differentiation and stimulated osteoblastic cell proliferation. An anti-sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) antibody inhibited multinucleated osteoclast formation induced by RANKL and macrophage colony-stimulating factor (M-CSF). Pit-forming activity of osteoclasts was also inhibited by the anti-Siglec-15 antibody. In addition, anti-Siglec-15 antibody treatment stimulated the appearance of osteoblasts in cultures of mouse bone marrow cells in the presence of RANKL and M-CSF.

Conclusions: Bone mass loss depends on the RANK-RANKL-OPG system, which is a major regulatory system of osteoclast differentiation induction, activation, and survival.

Keywords: Bone resorption; OPG; Osteoblast; Osteoclast; RANKL.

PubMed Disclaimer

References

    1. Rodan GA, Martin TJ (1981) Role of osteoblasts in hormonal control of bone resorption—a hypothesis. Calcif Tissue Int 33:349–351. https://doi.org/10.1007/BF02409454 - DOI - PubMed
    1. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acid Sci 87:7260–7264. https://doi.org/10.1073/pnas.87.18.7260 - DOI
    1. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Jane MM, Jone M, Suda T (1987) Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600–2602. https://doi.org/10.1210/endo-123-5-2600 - DOI
    1. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442–444. https://doi.org/10.1038/345442a0 - DOI - PubMed
    1. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acid Sci 95:3597–3602. https://doi.org/10.1073/pnas.95.7.3597 - DOI

LinkOut - more resources